DEAL ANNOUNCEMENT | SALE OF SHARES FORMMED

DEAL ANNOUNCEMENT | OX8 CORPORATE FINANCE ACTS AS EXCLUSIVE ADVISOR TO THE SHAREHOLDER OF FORMMED HEALTHCARE AG ON THE INVESTMENT BY AVEDON CAPITAL PARTNERS Aschaffenburg / Frankfurt am Main / Düsseldorf, 29. July 2022 ox8 Corporate Finance exclusively advised the shareholder of FormMed HealthCare AG (“FormMed”) on the investment by Avedon Capital Partners (“Avedon”). FormMed […]

FormMed

ox8 Corporate Finance exclusively advised the shareholder of FormMed HealthCare AG (“FormMed”) on the investment by Avedon Capital Partners (“Avedon”). FormMed is a leading developer and supplier of micronutrients for therapeutic use. The founder Dr. Martin Lemperle will retain a significant stake in the company and will actively shape its further development. When founding FormMed […]

Data protection
We, the ox8 Corporate Finance GmbH (Registered business address: Germany), would like to process personal information with external services. This is not necessary for the use of the website, but allows us to interact even more closely with them. If desired, please make a choice:
Data protection
We, the ox8 Corporate Finance GmbH (Registered business address: Germany), would like to process personal information with external services. This is not necessary for the use of the website, but allows us to interact even more closely with them. If desired, please make a choice: